| Literature DB >> 18292506 |
Sarah Kennedy Norton1, Brian Barnstein, Jennifer Brenzovich, Daniel P Bailey, Mohit Kashyap, Kelly Speiran, Jill Ford, Daniel Conrad, Stephanie Watowich, Matthew R Moralle, Christopher L Kepley, Peter J Murray, John J Ryan.
Abstract
Mast cells are known for their roles in allergy, asthma, systemic anaphylaxis, and inflammatory disease. IL-10 can regulate inflammatory responses and may serve as a natural regulator of mast cell function. We examined the effects of IL-10 on in vitro-cultured mouse and human mast cells, and evaluated the effects of IL-10 on FcepsilonRI in vivo using mouse models. IgE receptor signaling events were also assessed in the presence or absence of IL-10. IL-10 inhibited mouse mast cell FcepsilonRI expression in vitro through a Stat3-dependent process. This down-regulation was consistent in mice tested in vivo, and also on cultured human mast cells. IL-10 diminished expression of the signaling molecules Syk, Fyn, Akt, and Stat5, which could explain its ability to inhibit IgE-mediated activation. Studies of passive systemic anaphylaxis in IL-10-transgenic mice showed that IL-10 overexpression reduced the IgE-mediated anaphylactic response. These data suggest an important regulatory role for IL-10 in dampening mast cell FcepsilonRI expression and function. IL-10 may hence serve as a mediator of mast cell homeostasis, preventing excessive activation and the development of chronic inflammation.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18292506 DOI: 10.4049/jimmunol.180.5.2848
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422